Mongersen, an Oral <i>SMAD7</i> Antisense Oligonucleotide, and Crohn’s Disease

Giovanni Monteleone, Markus F. Neurath, Sandro Ardizzone, Antonio Di Sabatino, Massimo Claudio Fantini, Fabiana Castiglione, Maria Lia Scribano, Alessandro Armuzzi, Flavio Caprioli, Giacomo Carlo Sturniolo, Francesca Rogai, Maurizio Vecchi, Raja Atreya, Fabrizio Bossa, Sara Onali, Maria Fichera, Gino Roberto Corazza, Livia Biancone, Vincenzo Savarino, Roberta Pica, Ambrogio Orlando, Francesco Pallone

New England Journal of Medicine, 2015

University of Rome Tor Vergata, Nini Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg, Luigi Sacco Hospital, University of Pavia, University of Naples Federico II, Azienda Ospedaliera San Camillo-Forlanini, Catholic University of America, University of Milan, University of Padua, Azienda Ospedaliero-Universitaria Careggi, IRCCS Policlinico San Donato, Casa Sollievo della Sofferenza, University of Genoa, Ospedale Sandro Pertini, Ospedale Vincenzo Cervello

View Free PDF Publisher Website

Abstract

This research paper explore the methodology and findings associated with New England Journal of Medicine. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).

394

Citations

View on Google Scholar

Mongersen, an Oral <i>SMAD7</i> Antisense Oligonucleotide, and Crohn’s Disease

Abstract

Journal Details

Join JournalsHub

Welcome Back